Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
xBiotech Inc (XBIT)  
$7.87 0.34 (4.14%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 29,260,000
Market Cap: 230.28(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.27 - $9.89
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   XBiotech is a biopharmaceutical company that discovers and develops True Human™ monoclonal antibodies for treating a variety of diseases. Co. has developed a pipeline of product candidates targeting both inflammatory and infectious diseases. An area of medical focus for Co. are therapies that block a substance naturally produced by body, known as interleukin-1 alpha, that mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting and inflammation. Co.'s product development includes: Natrunix program, which is for the indication of pancreatic cancer and rheumatoid arthritis, and Hutrukin program, which is for the indication of stroke.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 124
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Simard John Chief Executive Officer   •       •       •   2021-03-22 4 OE $7.50 $3,750,000 D/D 500,000 4,223,166     -
   Bay Street Financial S.a. 10% Owner   –       –       •   2020-12-18 4 S $18.78 $22,029,560 D/D (1,173,033) 1,981,515 -0%     
   Bay Street Financial S.a. 10% Owner   –       –       •   2020-12-02 4 S $18.42 $3,367,839 D/D (182,836) 3,154,548 10%     
   Mckenzie W Thorpe Director   –       •       •   2020-11-19 4 S $18.30 $6,862,500 D/D (375,000) 2,560,964 13%     
   Simard John Chief Executive Officer   •       •       •   2020-09-18 4 D $0.00 $0 D/D (500,000) 3,723,166     -
   Shivaswamy Sushma Chief Scientific Officer   •       –      –    2020-09-15 4 S $20.00 $413,360 D/D (20,668) 0 9%     
   Shivaswamy Sushma Chief Scientific Officer   •       –      –    2020-09-15 4 OE $7.50 $155,010 D/D 20,668 20,668     -
   Shivaswamy Sushma Chief Scientific Officer   •       –      –    2020-09-10 4 S $20.01 $386,833 D/D (19,332) 0 16%     
   Shivaswamy Sushma Chief Scientific Officer   •       –      –    2020-09-10 4 OE $7.50 $144,990 D/D 19,332 19,332     -
   Han Queena VP Finance & HR   •       –      –    2020-09-01 4 OE $4.16 $242,399 D/D 57,692 57,692     -
   Han Queena VP Finance & HR   •       –      –    2020-08-24 4 S $19.65 $1,018,899 D/D (51,841) 0 18%     
   Han Queena VP Finance & HR   •       –      –    2020-08-24 4 OE $4.14 $346,000 D/D 51,841 12,500     -
   Han Queena VP Finance & HR   •       –      –    2020-08-17 4 S $19.30 $25,090 D/D (1,300) 0 18%     
   Han Queena VP Finance & HR   •       –      –    2020-08-17 4 OE $7.50 $9,750 D/D 1,300 1,300     -
   Bay Street Financial S.a. 10% Owner   –       –       •   2020-02-19 4 S $6.38 $10,607,490 D/D (1,662,616) 3,337,384 1%     
   Simard John Chief Executive Officer   •       •       •   2020-02-12 4/A D $30.00 $63,116,820 D/D (2,103,894) 4,223,166     -
   Waldin Jan-Paul Director   –       •      –    2020-02-12 4/A D $30.00 $2,992,710 D/D (99,757) 200,243     -
   Mckenzie W Thorpe Director   –       •       •   2020-02-12 4/A D $30.00 $1,588,530 I/I (52,951) 31,864     -
   Mckenzie W Thorpe Director   –       •       •   2020-02-12 4/A D $30.00 $43,879,080 D/D (1,462,636) 2,935,964     -
   Gut Thomas 10% Owner   –       –       •   2020-02-12 4/A D $30.00 $58,497,870 D/D (1,949,929) 3,914,111     -
   Gut Thomas 10% Owner   –       –       •   2020-02-12 4/A D $30.00 $58,427,520 D/D (1,947,584) 3,916,456     -
   Gut Thomas 10% Owner   –       –       •   2020-02-12 4 D $30.00 $56,066,100 D/D (1,868,870) 3,995,170     -
   Simard John Chief Executive Officer   •       •       •   2020-02-12 4 D $30.00 $60,493,980 D/D (2,016,466) 4,310,594     -
   Mckenzie W Thorpe Director   –       •       •   2020-02-12 4 D $30.00 $1,522,470 I/I (50,749) 32,524     -
   Mckenzie W Thorpe Director   –       •       •   2020-02-12 4 D $30.00 $42,055,680 D/D (1,401,856) 2,996,744     -
  124 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us